Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 2.785
-0.025 (-0.89%)
Jul 15, 2026, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 917.6 million as of July 15, 2026. Its market cap has increased by 51.56% in one year.
Market Cap
917.60M
Enterprise Value
440.86M
Revenue
5.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.79
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 917.60M, a decrease of -83.39%. That is a compound annual growth rate of -24.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 909.43M | 15.46% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 1.75B |
| Thor Medical ASA | 1.50B |
| ArcticZymes Technologies ASA | 970.36M |
| Lytix Biopharma ASA | 767.46M |
| Zelluna ASA | 647.10M |
| Oncoinvent ASA | 338.57M |
| SoftOx Solutions AS | 235.20M |
| Arctic Bioscience AS | 87.61M |